About Jennifer Ahlstrom
Articles by Jennifer Ahlstrom
Racial Disparities in Multiple MyelomaNov 06, 2018
New Drug for Myeloma Targeting Myeloma Cell Survival PathwayNov 06, 2018
Can Comedy Help Cure Cancer? Spellchek Features HealthTree on a Viral Video.Oct 29, 2018
What is Neutropenia? What Does it Mean to Myeloma Patients?Oct 27, 2018
What is Stem Cell Collection and How Long Does it Take?Oct 27, 2018
The Myeloma Crowd Launches HealthTree® Aimed at Accelerating a Cure for Multiple MyelomaOct 25, 2018
Clinical Trial: Phase II Antibody Drug Conjugate Trial for Relapsed/Refractory Myeloma PatientsOct 24, 2018
Engineered Toxin Bodies (EBTs), a New Treatment Approach for Multiple MyelomaOct 16, 2018
New Jersey: Hackensack Meridian Health's New Myeloma InstituteOct 14, 2018
The Three Most Common Genes for African American Multiple Myeloma PatientsOct 11, 2018
Higher Risk of MGUS in Immediate Family Members with Multiple MyelomaOct 11, 2018
Stem Cell Transplant as a Multiple Myeloma ImmunotherapyOct 10, 2018
Stating the Obvious: Having Drug Insurance Coverage Improves Outcomes for Myeloma Medicare PatientsOct 05, 2018
MRD Test by Adaptive (clonoSEQ) Gains FDA Approval in Multiple MyelomaOct 03, 2018
Obesity in Myeloma: Abdominal Fat Better than BMI to Predict Multiple MyelomaOct 03, 2018
CAR T Therapy Update by Edward Stadtmauer, MD, University of PennsylvaniaSep 29, 2018
In Memory of Multiple Myeloma Patient John RunyonSep 22, 2018
Multiple Myeloma HealthTree Stories: Brenda JenkinsSep 22, 2018
Amgen Advances the Immunotherapy Race in Multiple MyelomaSep 13, 2018
Earlier Treatment for Some Smoldering Myeloma Patients? Dana Farber Researchers Study Smoldering Myeloma Genetic FeaturesSep 12, 2018
Dear Doctor, My Common Symptoms Could be Multiple Myeloma, by Jim Omel, MDSep 07, 2018
Empliciti, Pomalyst and Low-Dose Dex Combination Receives FDA Priority Review for Relapsed MyelomaAug 31, 2018
How the CAR-T Myeloma Trial Gave Me My Life Back, by Cherie RinekerAug 22, 2018
Clinical Trial: New Inhibitor Tested for Patients With Relapsed or Refractory Multiple MyelomaAug 09, 2018
